Pembrolizumab Monotherapy Demonstrates PFS Benefit Over Brentuximab Vedotin in Relapsed or Refractory Classical Hodgkin Lymphoma
Circulating Tumor DNA in Lymphoma: Principles and Future Directions
Dr. Mark Roschewski, MD – Germantown, MD | Hematology
Dr. Mark Roschewski, MD - Hematology Specialist in Bethesda, MD | Healthgrades
Cellular therapy and drug access for viral lymphomas | VJHemOnc
Congress Report
Post-ASH 2021 iwNHL Highlights – International Workshop on Non-Hodgkin Lymphoma
40+ Profile mit dem Suchbegriff „Roschewski“ | LinkedIn
5F9 plus rituximab take a bite out of drug-resistant NHL | MDedge Hematology and Oncology
Safety and efficacy of escalating doses of Hu5F9-G4 with rituximab in patients with R/R DLBCL and indolent lymphoma - ecancer
Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable responses in R/R DLBCL and indolent lymphoma - ecancer
Mark Roschewski Phone Number, Address, Age, Contact Info, Public Records ᐈ Radaris
Lymphoid Malignancies Branch Clinical Research Team | Center for Cancer Research
Roschewski-Mark-IV-hematology_forum_2016
Mark Roschewski (@RoschewskiMD) / Twitter
Mark Roschewski (@RoschewskiMD) / Twitter
Acalabrutinib and AZD9150 combination for the treatment of R/R DLBCL | VJHemOnc
PDF) Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin Lymphoma
Mark Roschewski, M.D. | Center for Cancer Research
Mark Roschewski, M.D. | Principal Investigators | NIH Intramural Research Program
PHS Ceremony Promotes 24 Officers | NIH Record
Dr. Roschewski on the Treatment of Burkitt Lymphoma in Adults
Information for Patients with Aggressive Lymphomas
Mark Roschewski on Twitter: "Catching up with former members of our research team. I cannot overstate the importance of dedicated research nurses. They do a majority of the heavy lifting for us @NCICCR_Lymphoma as we try to make progress ...
Mark Roschewski (@RoschewskiMD) / Twitter
Mark ROSCHEWSKI | Staff Clinician | National Cancer Institute (USA), Bethesda | NCI | Center for Cancer Research | Research profile
